Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Trading Statement

21st Apr 2015 07:00

RNS Number : 7609K
Immunodiagnostic Systems Hldgs PLC
21 April 2015
 



21 April 2015

 

Immunodiagnostic Systems Holdings plc

 

Trading Update

 

 

Immunodiagnostic Systems Holdings plc ("the Group"), a leading solution provider to the clinical laboratory diagnostic market, today provides a trading update for the year ended 31 March 2015.

 

Total revenues are expected to be c. £45 million (2014: £52 million) in line with guidance given in September 2014. The decrease in revenue was driven by lower automated revenues, due to a low level of net placements, and continued significant decline in manual revenues, predominantly in 25OH vitamin D.

 

Direct instruments are those sold or placed with reagent rental IDS end-user customers in the Group's core markets of the USA and Europe (excluding distributor territories of Spain and Italy). Gross direct instrument placements were 54 (2014: 60) with 40 instruments returned in the year (2014: 25), meaning net direct instrument placements were 14 (2014: 35).The total number of instruments sold to or placed with distributors or OEM partners (net) during the year was 40 (2014: 57).

 

Closing cash and cash equivalents were c. £24 million as at 31 March 2015 (31 March 2014: £27 million; 30 September 2014: £23 million).

 

Preliminary results for the year ended 31 March 2015 will be announced on 23 June 2015.

 

For further information:

 

Immunodiagnostic Systems Holdings plc

Tel : +44 (0)191 5190660

Patricio Lacalle, Chief Executive Officer

Chris Yates, Finance Director

 

 

 

 

 Peel Hunt LLP

 

Tel : +44 (0)207 418 8900

 James Steel

 Clare Terlouw

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZDVGDGKZM

Related Shares:

IDH.L
FTSE 100 Latest
Value8,684.56
Change50.81